Penicillin derivatives inhibit the SARS-CoV-2 main protease by reaction with its nucleophilic cysteine
<p>The SARS-CoV-2 main protease (M<sup>pro</sup>) is a medicinal chemistry target for COVID-19 treatment. Given the clinical efficacy of β-lactams as inhibitors of bacterial nucleophilic enzymes, they are of interest as inhibitors of viral nucleophilic serine and cysteine...
Autors principals: | , , , , , , , , , , , |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
American Chemical Society
2022
|